Alzinova

Early-stage, public, Swedish Biotech company developing oligomer-directed vaccine and mAbs for Alzheimers' Disease treatment.

placeGothenburg, Vastra Gotaland County, Sweden calendar_todayFounded 2011 groups4 employees language alzinova.com

Social engagement

Social engagement: 3K social following, 9 posts in the last 12 months — above the industry median.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Accelerator & incubator125%
Other / undisclosed125%

Recent activity

24 Jun 2026
Partnership
Furebio
1 Jun 2026
Event
BIO International Convention 2026
Coming soon